CSIMarket
 
Aspire Biopharma Holdings Inc   (NASDAQ: ASBP)
 
Price: $9.2500 $0.05 0.489%
Day's High: $9.409700393676758 Week Perf: 8.7 %
Day's Low: $ 9.10 30 Day Perf: 27.41 %
Volume (M): 26,960 52 Wk High: $ 23.44
Volume (M$): $ 0 52 Wk Avg: $6.00
Open: $9.13 52 Wk Low: $0.11



 Market Capitalization (Millions $) 10
 Shares Outstanding (Millions) 1
 Employees 45
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Aspire is an early-stage biopharmaceutical company developing sublingual drug delivery technologies, with an initial focus on aspirin products. Their technology facilitates rapid sublingual absorption of drugs, bypassing the gastrointestinal tract. The company is conducting clinical trials to support FDA approval of a high-dose sublingual aspirin product intended for heart attack and stroke prevention.


   Company Address: 23150 Fashion Drive Estero 33928 FL
   Company Phone Number: 987-3002   Stock Exchange / Ticker: NASDAQ ASBP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 93.51
Price to Sales (Expected) -
Price to Book 0.82
PEG (TTM) -

Financial Strength Current
Quick Ratio 7.22
Working Capital Ratio 7.99
Leverage Ratio (MRQ) 0.15
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -21.86 $
Revenues (TTM) 0.1 $
Cash Flow (TTM) 5.44 $
Cash 11.72 $
Book Value 11.33 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 2,282
Net Income per Employee (TTM) -245,539
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) 0.34
Asset Turnover Ratio (TTM) 0.02

Profitability Ratios Current
Gross Margin (MRQ) 19.47 %
Operating Margin (MRQ) -4244.14 %
Net Margin (MRQ) -2009.61 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Aspire Biopharma Holdings Inc's Segments
Nutraceutical Products    7.94 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.